Ikena Oncology declares one-time CVR dividend; record date July 24, 2025

ImageneBio, Inc.

Board approved one contingent value right (CVR) per share of IKNA common stock.
Shareholders of record as of July 24, 2025 will receive one CVR per share.
CVRs entitle holders to net proceeds from sales of pre-Merger assets, including IK-595.
Proceeds subject to deductions for taxes, expenses, and wind-down costs.
No assurance any CVR payments will be received; CVRs may have no value.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.